<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02789098</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A01650-49</org_study_id>
    <nct_id>NCT02789098</nct_id>
  </id_info>
  <brief_title>Relationship Between Left Ventricular Remodeling, Coronary Endothelial Function and Myocardial Fibrosis Using Positron Emission Tomography in Patients With ST-elevation Myocardial Infarction</brief_title>
  <acronym>REMOD-TEP</acronym>
  <official_title>Assessment of Coronary Endothelial Function and Myocardial Fibrosis in Positron Emission Tomography With the Waning of Acute Coronary Syndrome With Elevated ST Segment : Relationship With Left Ventricular Remodeling</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Société Française de Cardiologie</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Left ventricular remodeling is a common complication in patients with ST-elevation myocardial
      infarction (STEMI ) and may lead to heart failure. Hemodynamic, metabolic and inflammatory
      mechanisms are involved in this pathophysiological process. Recent data demonstrated that
      remote, noninfarct-related region of the myocardium is also implicated. There is no data
      about the assessment of coronary endothelial function or myocardial fibrosis in the remote
      zone in patients with STEMI . The correlation between these parameters and left ventricular
      remodeling is not known.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of coronary endothelial function</measure>
    <time_frame>3 months</time_frame>
    <description>3 months following an acute coronary syndrome STEMI an ST segment (segments in myocardial infarcted area and &quot;remote&quot; ) .</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of fibrosis</measure>
    <time_frame>3 months</time_frame>
    <description>3 months following an acute coronary syndrome STEMI an ST segment (segments in myocardial infarcted area and &quot;remote&quot; ) .</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlating biomarkers with local and global parameters of coronary endothelial function , inflammation and myocardial fibrosis with early echocardiographic parameters of left ventricular remodeling and cardiac magnetic resonance imaging</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>ST Elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>STEMI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All patients included in this study (1 arm)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>(15)-O water positron emission tomography and Biomarkers</intervention_name>
    <description>Coronary endothelial function is assessed using (15)-O water positron emission tomography and cold pressor test . The response to the test is defined by the percentage increase myocardial blood flow . Assessment of fibrosis, inflammation an endothelial function is performed using biomarkers.</description>
    <arm_group_label>STEMI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  First ST Elevation Myocardial Infarction

          -  Primary Percutaneous Coronary Intervention (TIMI 3)

          -  Single vessel coronary artery disease

          -  Age over 18 years

          -  Informed Consent dated and signed

          -  Written and spoken French

          -  Beneficiary of social security insurance

        Exclusion Criteria:

          -  No Primary Percutaneous Coronary Intervention

          -  TIMI 0-2 after Primary Percutaneous Coronary Intervention

          -  Significant two or three-vessel coronary artery disease (&gt; 70% stenosis in at least
             one of the other two coronary arteries)

          -  Past history of myocardial infarction before STEMI

          -  Mechanical complication (ischaemic mitral regurgitation, interventricular septal
             defect, cardiac tamponade) or clinical signs of heart failure

          -  Pregnant and / or lactating

          -  Age under 18 years or guardianship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Farzin GF BEYGUI, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>CHU Caen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alain MA Manrique, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>CHU Caen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Damien LD Legallois, MD</last_name>
    <phone>02.31.06.51.18</phone>
    <phone_ext>+33</phone_ext>
    <email>legallois-da@chu-caen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cathy GC Gaillard</last_name>
    <phone>02 31 06 53 49</phone>
    <phone_ext>+33</phone_ext>
    <email>gaillard-c@chu-caen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHu de Caen</name>
      <address>
        <city>Caen</city>
        <state>Normandie</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Damien LEGALLOIS, MD</last_name>
      <phone>+33 231065704</phone>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2016</study_first_submitted>
  <study_first_submitted_qc>May 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2016</study_first_posted>
  <last_update_submitted>January 31, 2017</last_update_submitted>
  <last_update_submitted_qc>January 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ST Elevation Myocardial Infarction</keyword>
  <keyword>Ventricular remodeling</keyword>
  <keyword>Biomarkers</keyword>
  <keyword>Coronary endothelial function</keyword>
  <keyword>Positron Emission Tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Ventricular Remodeling</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

